SWOG researchers give #ASCO26 oral presentations on results of 2 GI trials, a testicular cancer study, work on vit D & neuropathy, big-picture results from S1609 DART rare cancers trial, & an AI prediction model in breast cancer! @SWOG ASCO calendar is at swog.org/media/26051.

"@LungMAP is the most transformative & pivotal trial in the MET Crusaders right now." Hear MET Crusaders Chair Marcia K. Horn, JD, on 3 current @LungMAP studies for patients with advanced #NSCLC with MET biomarkers. @metcrusaders #lcsm #ClinicalTrials youtube.com/watch?v=H1mxk7qM…

The S2409 PRISM #ClinicalTrial asks if we can treat extensive stage small cell lung cancer more effectively by targeting the vulnerabilities of specific molecular subtypes of the disease. #SCLC #LCSM PI: @AnneChiangMD @YaleCancer swog.org/clinical-trials/S24… @LaurenByersMD @BadiyanMD

Blog post from SWOG chairs @DrDawnHershman & @PrimoLaraMD: SWOG Establishes An APP & Nurse Scientist Cmte Our new cmte recognizes the contributions of APPs & nurse scientists & will help empower more of them to contribute to their full scope of practice. swog.org/news-events/news/20…

Front Line post by @SWOG chairs @DrDawnHershman & @PrimoLaraMD: The Next Era of SWOG Success We see trials that are more streamlined & decentralized, that integrate community & advocate voices, that ask questions only public-powered research will answer. swog.org/news-events/news/20…

Our @SWOG Chairs' blog: A Team Science Leadership Team SWOG is all about interdisciplinary collaboration and team science. We think a leadership approach with dual principal investigators who bring complementary skillsets and expertise is a great fit. swog.org/news-events/news/20…

Saying Thank You: @SWOGChair Dr. Charles Blanke's last Front Line post as chair of @SWOG: "I have been honored to serve as chair of this research group over the last 13 years, and I could not be prouder of what you have accomplished in that time." swog.org/news-events/news/20…

15-year results from @SWOG S0016 trial suggest follicular lymphoma is curable. Cure modeling estimates a 42% cure rate among S0016 patients. Relapse rates drop markedly over time. Study is in Feb 26 @JAMAOnc @DrJFriedberg @mshadman @WilmotCancer @FredHutch swog.org/news-events/news/20…

Registration is open for SWOG's spring group meeting, April 30-May 2, in San Francisco! Incoming Group Chairs Drs. Primo Lara, Jr., & Dawn Hershman invite SWOG members to bring questions, concerns, & ideas to an interactive Friday plenary. Learn more at swog.org/news-events/swog-me…

"Cancer statistics, 2026: Charting a course for a national cancer research agenda," commentary by @PrimoLaraMD & @DrDawnHershman publ w the annual portrait of U.S. #cancer stats in CA: A Cancer Journal for Clinicians, just out! #NCTN #NCORP @theNCI doi.org/10.3322/caac.70061

S2213 is a randomized ph 3 to definitively learn role of transplant in pts newly diagnosed w AL #amyloidosis. @BMTCTN Champion: @adsouza_md SWOG.org/clinical-trials/S22…